Botanix Pharmaceuticals Limited
BXPHF
$0.25
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -464.91% | -478.11% | -81.91% | -77.42% | -17.85% |
| Total Depreciation and Amortization | 13,392.59% | 13,278.57% | -32.59% | -34.06% | -50.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -146.59% | -147.69% | -0.48% | -2.94% | 246.35% |
| Change in Net Operating Assets | -- | -- | 127.68% | 126.99% | -- |
| Cash from Operations | -712.66% | -731.68% | 32.09% | 33.77% | 34.97% |
| Capital Expenditure | -150.00% | -156.78% | -2,700.00% | -2,700.00% | -637.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.82% | 94.70% | -60.15% | -56.20% | -185.98% |
| Cash from Investing | 94.22% | 94.09% | -63.82% | -59.78% | -186.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.37% | -98.37% | 615.90% | 615.90% | 110.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -580.05% | -580.05% | -91.55% |
| Cash from Financing | -98.50% | -98.47% | 610.95% | 593.40% | 111.33% |
| Foreign Exchange rate Adjustments | 190.89% | 193.05% | -28.44% | -30.15% | 42.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -482.83% | -491.78% | 3,820.64% | 3,723.83% | 458.66% |
